Literature DB >> 28938416

Pancreatic Histopathology of Human Monogenic Diabetes Due to Causal Variants in KCNJ11, HNF1A, GATA6, and LMNA.

May Sanyoura1, Laura Jacobsen2, David Carmody1, Daniela Del Gaudio3, Gorka Alkorta-Aranburu3, Kelly Arndt3, Ying Hu3, Frances Kobiernicki3, Irina Kusmartseva4, Mark A Atkinson4, Louis H Philipson1, Desmond Schatz2, Martha Campbell-Thompson4, Siri Atma W Greeley1.   

Abstract

Context: Monogenic diabetes is thought to account for 2% of all diabetes cases, but most patients receive misdiagnoses of type 1 or type 2 diabetes. To date, little is known about the histopathological features of pancreata from patients with monogenic diabetes. Objective: Retrospective study of the JDRF Network for Pancreatic Organ Donors with Diabetes biorepository to identify possible cases of monogenic diabetes and to compare effects of genetic variants on pancreas histology.
Methods: We selected cases of diabetes for genetic testing on the basis of criteria that included young age at diagnosis, low body mass index, negative autoantibody status, and/or detectable C-peptide level. Samples underwent next-generation-targeted sequencing of 140 diabetes/diabetes-related genes. Pancreas weight and histopathology were reviewed.
Results: Forty-one of 140 cases of diabetes met the clinical inclusion criteria, with 38 DNA samples available. Genetic variants of probable clinical significance were found in four cases: one each in KCNJ11, HNF1A, GATA6, and LMNA. The KCNJ11 and HNF1A samples had significantly decreased pancreas weight and insulin mass similar to that of type 1 diabetes but had no insulitis. The GATA6 sample had severe pancreatic atrophy but with abundant β cells and severe amyloidosis similar to type 2 diabetes. The LMNA sample had preserved pancreas weight and insulin mass but abnormal islet architecture and exocrine fatty infiltrates. Conclusions: Four cases of diabetes had putative causal variants in monogenic diabetes genes. This study provides further insight into the heterogeneous nature of monogenic diabetes cases that exhibited clinical and pathophysiological features that overlap with type 1/type 2 diabetes.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28938416      PMCID: PMC5761488          DOI: 10.1210/jc.2017-01159

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  41 in total

1.  Prevalence of variants in candidate genes for type 2 diabetes mellitus in The Netherlands: the Rotterdam study and the Hoorn study.

Authors:  L M Hart; R P Stolk; J M Dekker; G Nijpels; D E Grobbee; R J Heine; J A Maassen
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

2.  Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12.

Authors:  M M Byrne; J Sturis; S Menzel; K Yamagata; S S Fajans; M J Dronsfield; S C Bain; A T Hattersley; G Velho; P Froguel; G I Bell; K S Polonsky
Journal:  Diabetes       Date:  1996-11       Impact factor: 9.461

3.  Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism.

Authors:  Valérie Senée; Claude Chelala; Sabine Duchatelet; Daorong Feng; Hervé Blanc; Jack-Christophe Cossec; Céline Charon; Marc Nicolino; Pascal Boileau; Douglas R Cavener; Pierre Bougnères; Doris Taha; Cécile Julier
Journal:  Nat Genet       Date:  2006-05-21       Impact factor: 38.330

4.  Human pancreas endocrine cell populations and activating ABCC8 mutations.

Authors:  Kanetee Busiah; Virginie Verkarre; Hélène Cavé; Raphael Scharfmann; Michel Polak
Journal:  Horm Res Paediatr       Date:  2014-06-14       Impact factor: 2.852

5.  Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes.

Authors:  Maggie Shepherd; Beverley Shields; Suzanne Hammersley; Michelle Hudson; Timothy J McDonald; Kevin Colclough; Richard A Oram; Bridget Knight; Christopher Hyde; Julian Cox; Katherine Mallam; Christopher Moudiotis; Rebecca Smith; Barbara Fraser; Simon Robertson; Stephen Greene; Sian Ellard; Ewan R Pearson; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2016-06-06       Impact factor: 19.112

6.  Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.

Authors:  Gaya Thanabalasingham; Aparna Pal; Mary P Selwood; Christina Dudley; Karen Fisher; Polly J Bingley; Sian Ellard; Andrew J Farmer; Mark I McCarthy; Katharine R Owen
Journal:  Diabetes Care       Date:  2012-03-19       Impact factor: 19.112

7.  The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study.

Authors:  Elisa De Franco; Sarah E Flanagan; Jayne A L Houghton; Hana Lango Allen; Deborah J G Mackay; I Karen Temple; Sian Ellard; Andrew T Hattersley
Journal:  Lancet       Date:  2015-07-28       Impact factor: 79.321

8.  GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim.

Authors:  Tatiane C Nogueira; Flavia M Paula; Olatz Villate; Maikel L Colli; Rodrigo F Moura; Daniel A Cunha; Lorella Marselli; Piero Marchetti; Miriam Cnop; Cécile Julier; Decio L Eizirik
Journal:  PLoS Genet       Date:  2013-05-30       Impact factor: 5.917

9.  GATA6 mutations cause a broad phenotypic spectrum of diabetes from pancreatic agenesis to adult-onset diabetes without exocrine insufficiency.

Authors:  Elisa De Franco; Charles Shaw-Smith; Sarah E Flanagan; Maggie H Shepherd; Andrew T Hattersley; Sian Ellard
Journal:  Diabetes       Date:  2012-12-06       Impact factor: 9.461

10.  Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes.

Authors:  Martha Campbell-Thompson; Ann Fu; John S Kaddis; Clive Wasserfall; Desmond A Schatz; Alberto Pugliese; Mark A Atkinson
Journal:  Diabetes       Date:  2015-11-18       Impact factor: 9.461

View more
  10 in total

1.  Human islets expressing HNF1A variant have defective β cell transcriptional regulatory networks.

Authors:  Rachana Haliyur; Xin Tong; May Sanyoura; Shristi Shrestha; Jill Lindner; Diane C Saunders; Radhika Aramandla; Greg Poffenberger; Sambra D Redick; Rita Bottino; Nripesh Prasad; Shawn E Levy; Raymond D Blind; David M Harlan; Louis H Philipson; Roland W Stein; Marcela Brissova; Alvin C Powers
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

2.  Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes.

Authors:  Martha L Campbell-Thompson; Stephanie L Filipp; Joseph R Grajo; Bimota Nambam; Richard Beegle; Erik H Middlebrooks; Matthew J Gurka; Mark A Atkinson; Desmond A Schatz; Michael J Haller
Journal:  Diabetes Care       Date:  2018-12-14       Impact factor: 19.112

3.  Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes.

Authors:  A L J Carr; D J Perry; A L Lynam; S Chamala; C S Flaxman; S A Sharp; L A Ferrat; A G Jones; M L Beery; L M Jacobsen; C H Wasserfall; M L Campbell-Thompson; I Kusmartseva; A Posgai; D A Schatz; M A Atkinson; T M Brusko; S J Richardson; B M Shields; R A Oram
Journal:  Diabet Med       Date:  2020-07-23       Impact factor: 4.359

Review 4.  Use of human islets to understand islet biology and diabetes: progress, challenges and suggestions.

Authors:  Nathaniel J Hart; Alvin C Powers
Journal:  Diabetologia       Date:  2018-12-14       Impact factor: 10.122

Review 5.  Congenital Diabetes: Comprehensive Genetic Testing Allows for Improved Diagnosis and Treatment of Diabetes and Other Associated Features.

Authors:  Lisa R Letourneau; Siri Atma W Greeley
Journal:  Curr Diab Rep       Date:  2018-06-13       Impact factor: 4.810

6.  α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes.

Authors:  Marcela Brissova; Rachana Haliyur; Diane Saunders; Shristi Shrestha; Chunhua Dai; David M Blodgett; Rita Bottino; Martha Campbell-Thompson; Radhika Aramandla; Gregory Poffenberger; Jill Lindner; Fong Cheng Pan; Matthias G von Herrath; Dale L Greiner; Leonard D Shultz; May Sanyoura; Louis H Philipson; Mark Atkinson; David M Harlan; Shawn E Levy; Nripesh Prasad; Roland Stein; Alvin C Powers
Journal:  Cell Rep       Date:  2018-03-06       Impact factor: 9.423

7.  Islet amyloidosis in a child with type 1 diabetes.

Authors:  Maria L Beery; Laura M Jacobsen; Mark A Atkinson; Alexandra E Butler; Martha Campbell-Thompson
Journal:  Islets       Date:  2019-05-14       Impact factor: 2.694

8.  GATA6 mutations: Characterization of two novel patients and a comprehensive overview of the GATA6 genotypic and phenotypic spectrum.

Authors:  Doris Škorić-Milosavljević; Fleur V Y Tjong; Julien Barc; Ad P C M Backx; Sally-Ann B Clur; Karin van Spaendonck-Zwarts; Roelof-Jan Oostra; Najim Lahrouchi; Leander Beekman; Regina Bökenkamp; Daniela Q C M Barge-Schaapveld; Barbara J Mulder; Elisabeth M Lodder; Connie R Bezzina; Alex V Postma
Journal:  Am J Med Genet A       Date:  2019-07-12       Impact factor: 2.802

9.  An HNF1α truncation associated with maturity-onset diabetes of the young impairs pancreatic progenitor differentiation by antagonizing HNF1β function.

Authors:  Ana-Maria Cujba; Mario E Alvarez-Fallas; Sergio Pedraza-Arevalo; Anna Laddach; Maggie H Shepherd; Andrew T Hattersley; Fiona M Watt; Rocio Sancho
Journal:  Cell Rep       Date:  2022-03-01       Impact factor: 9.995

Review 10.  Modeling Maturity Onset Diabetes of the Young in Pluripotent Stem Cells: Challenges and Achievements.

Authors:  Carmel Braverman-Gross; Nissim Benvenisty
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-22       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.